Aura Biosciences, Inc. (AURA) Misses Q1 EPS by 6c

Aura Biosciences, Inc. (NASDAQ: AURA) reported Q1 EPS of ($0.50), $0.06 worse than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Aura Biosciences, Inc. (AURA) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Aura Biosciences (AURA) PT Lowered to $18 at H.C. Wainwright
• Desjardins Downgrades Alithya Group Inc. (ALYA:CN) (ALYA) to Hold